{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:34:27Z","timestamp":1761179667417,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,22]]},"DOI":"10.7759\/cureus.95156","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:10:16Z","timestamp":1761142216000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Polycystic Ovary Syndrome Phenotypes and Their Association With Vitamin D Levels, Insulin Resistance, and Homeostasis Model Assessment of Insulin Resistance in Women With Polycystic Ovary Syndrome: A Cross-Sectional Analysis"],"prefix":"10.7759","author":[{"given":"Anupama","family":"Bahadur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba","family":"Afreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayush","family":"Heda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajlaxmi","family":"Mundhra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Naithani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavi Latha","family":"Ratala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragati","family":"Jakhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushka","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilofer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva D","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016, 106:6-15. 10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield RL","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016, 37:467-520. 10.1210\/er.2015-1104","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Gnanadass AS","year":"2021","unstructured":"Gnanadass AS, Prabhu DY, Gopalakrishnan VA. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021, 303:631-43. 10.1007\/s00404-020-05951-2","journal-title":"Arch Gynecol Obstet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz R","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al.. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009, 91:456-88. 10.1016\/j.fertnstert.2008.06.035","journal-title":"Fertil Steril"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.08.005","article-title":"Questioning PCOS phenotypes for reclassification and tailored therapy","volume":"34","author":"Myers SH","year":"2023","unstructured":"Myers SH, Russo M, Dinicola S, Forte G, Unfer V. Questioning PCOS phenotypes for reclassification and tailored therapy. Trends Endocrinol Metab. 2023, 34:694-703. 10.1016\/j.tem.2023.08.005","journal-title":"Trends Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas J","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, et al.. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014, 2014:719050. 10.1155\/2014\/719050","journal-title":"Int J Reprod Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism","volume":"23","author":"Armanini D","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022, 23:4110. 10.3390\/ijms23084110","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154509","article-title":"PCOS physiopathology and vitamin D deficiency: biological insights and perspectives for treatment","volume":"11","author":"Morgante G","year":"2022","unstructured":"Morgante G, Darino I, Span\u00f2 A, et al.. PCOS physiopathology and vitamin D deficiency: biological insights and perspectives for treatment. J Clin Med. 2022, 11:4509. 10.3390\/jcm11154509","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103491","article-title":"Mechanisms involved in the relationship between vitamin D and insulin resistance: impact on clinical practice","volume":"13","author":"Contreras-Bol\u00edvar V","year":"2021","unstructured":"Contreras-Bol\u00edvar V, Garc\u00eda-Fontana B, Garc\u00eda-Fontana C, Mu\u00f1oz-Torres M. Mechanisms involved in the relationship between vitamin D and insulin resistance: impact on clinical practice. Nutrients. 2021, 13:10.3390\/nu13103491","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00874-2","article-title":"Polycystic ovary syndrome phenotype does not have impact on oocyte morphology","volume":"20","author":"Uk A","year":"2022","unstructured":"Uk A, Decanter C, Grysole C, et al.. Polycystic ovary syndrome phenotype does not have impact on oocyte morphology. Reprod Biol Endocrinol. 2022, 20:7. 10.1186\/s12958-021-00874-2","journal-title":"Reprod Biol Endocrinol"},{"key":"ref11","article-title":"The Asia-Pacific Perspective: Redefining Obesity and Its Treatment","year":"2000","unstructured":"The Asia-Pacific Perspective. Redefining Obesity and Its Treatment. Health Communications Australia, Sydney; 2000."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5021\/ad.23.094","article-title":"A comprehensive review of the Acne Grading Scale in 2023","volume":"36","author":"Bae IH","year":"2024","unstructured":"Bae IH, Kwak JH, Na CH, Kim MS, Shin BS, Choi H. A comprehensive review of the Acne Grading Scale in 2023. Ann Dermatol. 2024, 36:65-73. 10.5021\/ad.23.094","journal-title":"Ann Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-017-0097-2","article-title":"Chemiluminescent immunoassay technology: what does it change in autoantibody detection?","volume":"8","author":"Cinquanta L","year":"2017","unstructured":"Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent immunoassay technology: what does it change in autoantibody detection?. Auto Immun Highlights. 2017, 8:9. 10.1007\/s13317-017-0097-2","journal-title":"Auto Immun Highlights"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"Teede HJ","year":"2013","unstructured":"Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, Lombard C. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring). 2013, 21:1526-32. 10.1002\/oby.20213","journal-title":"Obesity (Silver Spring)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim SS","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012, 18:618-37. 10.1093\/humupd\/dms030","journal-title":"Hum Reprod Update"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka A","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009, 296:E238-43. 10.1152\/ajpendo.90684.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1933719115611751","article-title":"The role of anti-M\u00fcllerian hormone in the characterization of the different polycystic ovary syndrome phenotypes","volume":"23","author":"Romualdi D","year":"2016","unstructured":"Romualdi D, Di Florio C, Tagliaferri V, et al.. The role of anti-M\u00fcllerian hormone in the characterization of the different polycystic ovary syndrome phenotypes. Reprod Sci. 2016, 23:655-61. 10.1177\/1933719115611751","journal-title":"Reprod Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.03.007","article-title":"Serum AMH levels and insulin resistance in women with PCOS","volume":"224","author":"Sahmay S","year":"2018","unstructured":"Sahmay S, Aydogan Mathyk B, Sofiyeva N, Atakul N, Azemi A, Erel T. Serum AMH levels and insulin resistance in women with PCOS. Eur J Obstet Gynecol Reprod Biol. 2018, 224:159-64. 10.1016\/j.ejogrb.2018.03.007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/nu7064555","article-title":"Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"7","author":"He C","year":"2015","unstructured":"He C, Lin Z, Robb SW, Ezeamama AE. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients. 2015, 7:4555-77. 10.3390\/nu7064555","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04434.x","article-title":"Vitamin D in the aetiology and management of polycystic ovary syndrome","volume":"77","author":"Thomson RL","year":"2012","unstructured":"Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012, 77:343-50. 10.1111\/j.1365-2265.2012.04434.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2012.09.006","article-title":"Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome","volume":"6","author":"Patra SK","year":"2012","unstructured":"Patra SK, Nasrat H, Goswami B, Jain A. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr. 2012, 6:146-9. 10.1016\/j.dsx.2012.09.006","journal-title":"Diabetes Metab Syndr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000177","article-title":"Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?","volume":"64","author":"Eftekhar M","year":"2020","unstructured":"Eftekhar M, Mirhashemi ES, Molaei B, Pourmasumi S. Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?. Arch Endocrinol Metab. 2020, 64:11-6. 10.20945\/2359-3997000000177","journal-title":"Arch Endocrinol Metab"},{"key":"ref23","article-title":"Vitamin D deficiency is associated with metabolic risk factors in women with polycystic ovary syndrome: a cross-sectional study in Shaanxi China","volume":"11","author":"Wang L","year":"2020","unstructured":"Wang L, Lv S, Li F, Yu X, Bai E, Yang X. Vitamin D deficiency is associated with metabolic risk factors in women with polycystic ovary syndrome: a cross-sectional study in Shaanxi China. Front Endocrinol (Lausanne). 2020, 11:171.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/19407.7771","article-title":"Hypovitaminosis D and associated cardiometabolic risk in women with PCOS","volume":"10","author":"Mishra S","year":"2016","unstructured":"Mishra S, Das AK, Das S. Hypovitaminosis D and associated cardiometabolic risk in women with PCOS. J Clin Diagn Res. 2016, 10:BC01-4. 10.7860\/JCDR\/2016\/19407.7771","journal-title":"J Clin Diagn Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2020.1810228","article-title":"The correlation between vitamin D, glucose homeostasis and androgen level among polycystic ovary syndrome patients: a cross-sectional study","volume":"37","author":"Li Y","year":"2021","unstructured":"Li Y, Wang J, Yang J, et al.. The correlation between vitamin D, glucose homeostasis and androgen level among polycystic ovary syndrome patients: a cross-sectional study. Gynecol Endocrinol. 2021, 37:235-9. 10.1080\/09513590.2020.1810228","journal-title":"Gynecol Endocrinol"},{"key":"ref26","article-title":"Association between serum 25(OH) vitamin D and metabolic disturbances in polycystic ovary syndrome","volume":"75","author":"Keshavarz MA","year":"2017","unstructured":"Keshavarz MA, Moradi S, Emami Z, Rohani F. Association between serum 25(OH) vitamin D and metabolic disturbances in polycystic ovary syndrome. Neth J Med. 2017, 75:190-5.","journal-title":"Neth J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1760-8","article-title":"Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial","volume":"58","author":"Trummer C","year":"2019","unstructured":"Trummer C, Schwetz V, Kollmann M, et al.. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. Eur J Nutr. 2019, 58:2019-28. 10.1007\/s00394-018-1760-8","journal-title":"Eur J Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2016.11.008","article-title":"Effect of vitamin D supplementation on polycystic ovary syndrome: a\u00a0systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Fang F","year":"2017","unstructured":"Fang F, Ni K, Cai Y, Shang J, Zhang X, Xiong C. Effect of vitamin D supplementation on polycystic ovary syndrome: a\u00a0systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract. 2017, 26:53-60. 10.1016\/j.ctcp.2016.11.008","journal-title":"Complement Ther Clin Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376892-prevalence-of-polycystic-ovary-syndrome-phenotypes-and-their-association-with-vitamin-d-levels-insulin-resistance-and-homeostasis-model-assessment-of-insulin-resistance-in-women-with-polycystic-ovary-syndrome-a-cross-sectional-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:10:17Z","timestamp":1761142217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376892-prevalence-of-polycystic-ovary-syndrome-phenotypes-and-their-association-with-vitamin-d-levels-insulin-resistance-and-homeostasis-model-assessment-of-insulin-resistance-in-women-with-polycystic-ovary-syndrome-a-cross-sectional-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.95156","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}